⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4959977 | 0.74 | — | — | |
| SCHEMBL112567 | 0.73 | TSHR (0.36) | — | |
| SCHEMBL19496797 | 0.72 | — | — | |
| SCHEMBL8391681 | 0.71 | — | — | |
| SCHEMBL24141884 | 0.70 | — | — | |
| SCHEMBL17722541 | 0.70 | KDM1A (0.31) | — | |
| SCHEMBL12826510 | 0.70 | KDM1A (0.36) | — | |
| SCHEMBL17722544 | 0.70 | KDM1A (0.31) | — | |
| Fluoride SCHEMBL22032650 | 0.70 | TSHR (0.33) | — | |
| Hydrochloric Acid SCHEMBL4316309 | 0.70 | TSHR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12544338-B2 | Solid or semisolid lipid based dosage form stabilization through curing and addition of low HLB surfactant(s) | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2026-02-10 | — | — | US | disclosed |
| WO-2025264247-A1 | THERMOPLASTIC BLENDS FOR INJECTION MOLDING | PLANTSWITCH, INC (US) | 2025-12-26 | — | — | WO | disclosed |
| WO-2025264246-A1 | THERMOPLASTIC BLENDS FOR INJECTION MOLDING | PLANTSWITCH, INC (US) | 2025-12-26 | — | — | WO | disclosed |
| US-12434891-B2 | Degradable materials and packaging made from same | MONOSOL, LLC (US) | 2025-10-07 | — | — | US | disclosed |
| EP-4543455-A2 | METHODS OF TREATING NEUROLOGICAL VENTILATORY INSUFFICIENCY | Enalare Therapeutics Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| WO-2025080559-A1 | METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE | ENALARE THERAPEUTICS INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| US-20250114370-A1 | METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE | ENALARE THERAPEUTICS INC (US) | 2025-04-10 | — | — | US | disclosed |
| EP-4504206-A2 | RESPIRATORY STIMULANT NASAL FORMULATIONS | Enalare Therapeutics Inc. (US) | 2025-02-12 | — | — | EP | disclosed |
| US-20250031718-A1 | NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) COMPOSITIONS, METHODS OF MANUFACTURING THEREOF, AND METHODS OF USE THEREOF | SOVIDA SOLUTIONS LTD (GB) | 2025-01-30 | — | — | US | disclosed |
| US-20250032496-A1 | METHODS OF TREATING RESPIRATORY DEPRESSION MODULATED BY A NON-OPIOID AGENT | ENALARE THERAPEUTICS INC (US) | 2025-01-30 | — | — | US | disclosed |
| WO-2022197581-A1 | NON-ORAL MEDICATED CANNABINOID COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT | TAURIGA SCIENCES INC. (US) | 2022-09-22 | — | — | WO | disclosed |
| US-20220296561-A1 | NON-ORAL MEDICATED CANNABINOID COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT | TAURIGA SCIENCES INC (US) | 2022-09-22 | — | — | US | disclosed |
| EP-4051203-A1 | SUPPOSITORY CAPSULE | R.P. Scherer Technologies, LLC (US) | 2022-09-07 | — | — | EP | disclosed |
| US-20220017276-A1 | DEGRADABLE MATERIALS AND PACKAGING MADE FROM SAME | MONOSOL, LLC | 2022-01-20 | — | — | US | disclosed |
| US-20210308062-A1 | SOLID OR SEMISOLID LIPID BASED DOSAGE FORM STABILIZATION THROUGH CURING AND ADDITION OF LOW HLB SURFACTANT(S) | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2021-10-07 | — | — | US | disclosed |
| WO-2021188612-A1 | MEDICATED CANNABINOID COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT | TAURIGA SCIENCES INC. (US) | 2021-09-23 | — | — | WO | disclosed |
| US-20210290564-A1 | MEDICATED CANNABINOID COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT | TAURIGA SCIENCES INC. | 2021-09-23 | — | — | US | disclosed |
| EP-3846852-A1 | SOLID OR SEMISOLID LIPID BASED DOSAGE FORM STABILIZATION THROUGH CURING AND ADDITION OF LOW HLB SURFACTANT(S) | R.P. Scherer Technologies, LLC (US) | 2021-07-14 | — | — | EP | disclosed |
| WO-2021087210-A1 | SUPPOSITORY CAPSULE | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2021-05-06 | — | — | WO | disclosed |
| US-20170259976-A1 | DEGRADABLE MATERIALS AND PACKAGING MADE FROM SAME | MONOSOL, LLC (US) | 2017-09-14 | — | — | US | disclosed |